Tapsawani, Norsim B.
HRN: 22-17-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2022
CEFTRIAXONE 1G (VIAL)
11/05/2022
11/11/2022
IV
2gms
BID
Severe Typhoid Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes